Zoetis Inc. $ZTS Shares Acquired by AE Wealth Management LLC

AE Wealth Management LLC increased its position in shares of Zoetis Inc. (NYSE:ZTS) by 3,128.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 66,578 shares of the company’s stock after purchasing an additional 64,516 shares during the period. AE Wealth Management LLC’s holdings in Zoetis were worth $10,383,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Stokes Family Office LLC grew its position in Zoetis by 2.4% in the 2nd quarter. Stokes Family Office LLC now owns 3,357 shares of the company’s stock valued at $524,000 after acquiring an additional 78 shares in the last quarter. Fox Run Management L.L.C. lifted its position in shares of Zoetis by 25.7% during the 2nd quarter. Fox Run Management L.L.C. now owns 12,068 shares of the company’s stock worth $1,882,000 after purchasing an additional 2,466 shares during the last quarter. Metis Global Partners LLC boosted its position in shares of Zoetis by 1.8% during the 2nd quarter. Metis Global Partners LLC now owns 38,748 shares of the company’s stock worth $6,043,000 after acquiring an additional 678 shares in the last quarter. Wedbush Securities Inc. raised its holdings in Zoetis by 12.2% during the second quarter. Wedbush Securities Inc. now owns 9,167 shares of the company’s stock worth $1,430,000 after purchasing an additional 994 shares in the last quarter. Finally, Harvest Portfolios Group Inc. boosted its stake in Zoetis by 8.1% in the second quarter. Harvest Portfolios Group Inc. now owns 363,253 shares of the company’s stock valued at $56,649,000 after acquiring an additional 27,115 shares in the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on ZTS shares. JPMorgan Chase & Co. decreased their price target on shares of Zoetis from $230.00 to $200.00 and set an “overweight” rating for the company in a research note on Wednesday, November 5th. Argus reiterated a “buy” rating and issued a $190.00 price target on shares of Zoetis in a report on Tuesday, September 9th. UBS Group lowered their target price on Zoetis from $158.00 to $141.00 and set a “neutral” rating on the stock in a report on Wednesday, November 5th. Piper Sandler raised their price objective on shares of Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research note on Monday, August 11th. Finally, Stifel Nicolaus set a $140.00 target price on shares of Zoetis in a report on Tuesday, November 4th. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, Zoetis presently has an average rating of “Moderate Buy” and an average target price of $191.00.

Zoetis Price Performance

ZTS stock opened at $120.20 on Monday. The company has a market capitalization of $52.97 billion, a PE ratio of 20.69, a P/E/G ratio of 2.31 and a beta of 0.90. The stock’s 50 day moving average is $144.21 and its two-hundred day moving average is $152.63. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 1.05. Zoetis Inc. has a 52-week low of $117.26 and a 52-week high of $181.85.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.08. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The firm had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.42 billion. During the same quarter in the prior year, the firm posted $1.58 earnings per share. Zoetis’s revenue for the quarter was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date is Friday, October 31st. Zoetis’s payout ratio is 33.67%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.